SLC39A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62436730732907E-12 |
Normal-vs-Stage2 |
1.56149999996913E-06 |
Normal-vs-Stage3 |
2.25310003987289E-09 |
Normal-vs-Stage4 |
5.92200000149035E-09 |
Stage1-vs-Stage2 |
9.467200E-01 |
Stage1-vs-Stage3 |
5.574500E-02 |
Stage1-vs-Stage4 |
2.586000E-01 |
Stage2-vs-Stage3 |
2.597800E-01 |
Stage2-vs-Stage4 |
5.148200E-01 |
Stage3-vs-Stage4 |
6.268200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
3.1959999979847E-08 |
Normal-vs-Asian |
4.180300E-02 |
Caucasian-vs-AfricanAmerican |
6.166200E-01 |
Caucasian-vs-Asian |
3.119600E-01 |
AfricanAmerican-vs-Asian |
4.567600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.55111512312578E-15 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
5.118700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.439500E-04 |
Normal-vs-Age(41-60Yrs) |
1.62547753035369E-12 |
Normal-vs-Age(61-80Yrs) |
1.62503344114384E-12 |
Normal-vs-Age(81-100Yrs) |
1.564750E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.001600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.668200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.614200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.134000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.632200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.401800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.77010000000011E-05 |
Normal-vs-Grade 2 |
<1E-12 |
Normal-vs-Grade 3 |
4.39648317751562E-14 |
Normal-vs-Grade 4 |
5.80930004101532E-09 |
Grade 1-vs-Grade 2 |
5.419600E-02 |
Grade 1-vs-Grade 3 |
2.683600E-02 |
Grade 1-vs-Grade 4 |
2.524500E-03 |
Grade 2-vs-Grade 3 |
2.521200E-01 |
Grade 2-vs-Grade 4 |
5.794200E-02 |
Grade 3-vs-Grade 4 |
3.752400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62447832963153E-12 |
Normal-vs-ccB subtype |
1.19790000141506E-08 |
ccA subtype-vs-ccB subtype |
1.436640E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62669877568078E-12 |
Normal-vs-N1 |
1.995790E-03 |
N0-vs-N1 |
1.447990E-01 |
|
|